Policistinių kiaušidžių sindromo diagnostika ir gydymas: naujos gairės

The paper presents the first international clinical guidelines for diagnosing and treating polycystic ovary syndrome (PCOS), developed by a multidisciplinary expert group across six continents, and discusses updated recommendations published in August 2023. It highlights stronger evidence regarding increased risks for cardiovascular disease, impaired carbohydrate tolerance and type 2 diabetes, obstructive sleep apnea, and endometrial cancer in people with PCOS, while also emphasizing attention to psychological health and clarifying the evidence level supporting lifestyle interventions and medication effectiveness. New approaches for treating hirsutism and stronger recommendations for obesity pharmacotherapy and bariatric surgery are reviewed, along with principles for infertility management in PCOS. A major limitation noted is that for many guideline topics the evidence level remains low, indicating the need for further research. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works